All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
Syndicated LoansInvestment Grade Loans

GSK signs £3.8bn-equivalent of loans tied to RFRs

Glaxo 230x150 Brentford HQ

GlaxoSmithKlein, the UK pharmaceutical company, has refinanced dollar and sterling loans using risk-free rates, in one of the biggest transactions yet to avoid using Libor as the margin benchmark.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree